A detailed history of Efg Asset Management (North America) Corp. transactions in Natera, Inc. stock. As of the latest transaction made, Efg Asset Management (North America) Corp. holds 53,374 shares of NTRA stock, worth $8.64 Million. This represents 1.16% of its overall portfolio holdings.

Number of Shares
53,374
Previous 67,912 21.41%
Holding current value
$8.64 Million
Previous $7.35 Million 7.76%
% of portfolio
1.16%
Previous 1.3%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$97.75 - $129.67 $1.42 Million - $1.89 Million
-14,538 Reduced 21.41%
53,374 $6.78 Million
Q2 2024

Jul 25, 2024

SELL
$85.28 - $112.6 $2.38 Million - $3.14 Million
-27,872 Reduced 29.1%
67,912 $7.35 Million
Q1 2024

May 13, 2024

SELL
$59.21 - $92.9 $1.36 Million - $2.14 Million
-23,028 Reduced 19.38%
95,784 $8.76 Million
Q4 2023

Feb 08, 2024

SELL
$37.55 - $62.64 $204,534 - $341,200
-5,447 Reduced 4.38%
118,812 $7.44 Million
Q3 2023

Nov 02, 2023

SELL
$43.4 - $62.52 $251,372 - $362,115
-5,792 Reduced 4.45%
124,259 $5.5 Million
Q2 2023

Jul 28, 2023

BUY
$47.08 - $55.16 $112,521 - $131,832
2,390 Added 1.87%
130,051 $6.33 Million
Q1 2023

Apr 27, 2023

SELL
$36.57 - $58.29 $70,799 - $112,849
-1,936 Reduced 1.49%
127,661 $7.09 Million
Q4 2022

Feb 03, 2023

BUY
$34.17 - $47.91 $444,380 - $623,069
13,005 Added 11.15%
129,597 $5.21 Million
Q3 2022

Oct 28, 2022

SELL
$36.93 - $56.68 $164,966 - $253,189
-4,467 Reduced 3.69%
116,592 $5.1 Million
Q2 2022

Aug 04, 2022

BUY
$28.13 - $44.54 $1.18 Million - $1.86 Million
41,795 Added 52.73%
121,059 $4.29 Million
Q1 2022

Apr 26, 2022

BUY
$30.32 - $91.33 $865,454 - $2.61 Million
28,544 Added 56.28%
79,264 $3.23 Million
Q4 2021

Feb 18, 2022

BUY
$86.26 - $119.0 $4.38 Million - $6.04 Million
50,720 New
50,720 $4.74 Million

Others Institutions Holding NTRA

About Natera, Inc.


  • Ticker NTRA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 96,957,400
  • Market Cap $15.7B
  • Description
  • Natera, Inc., a diagnostics company, develops and commercializes molecular testing services worldwide. It offers Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother, as well as twin pregnancies for zygosity; Vistara, a single-gene mutations screening test to identify sing...
More about NTRA
Track This Portfolio

Track Efg Asset Management (North America) Corp. Portfolio

Follow Efg Asset Management (North America) Corp. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Efg Asset Management (North America) Corp., based on Form 13F filings with the SEC.

News

Stay updated on Efg Asset Management (North America) Corp. with notifications on news.